3582|1030|Public
5|$|Official bodies {{such as the}} European Centre for the Validation of Alternative Test Methods of the European Commission, the Interagency Coordinating Committee for the Validation of Alternative Methods in the US, ZEBET in Germany, and the Japanese Center for the Validation of Alternative Methods (among others) also {{promote and}} {{disseminate}} the 3Rs. These bodies are mainly driven by responding to <b>regulatory</b> <b>requirements,</b> such as supporting the cosmetics testing ban in the EU by validating alternative methods.|$|E
25|$|OFFICIAL {{may include}} data which {{is subject to}} {{separate}} <b>regulatory</b> <b>requirements,</b> such as the Data Protection Act (personal data) or PCI DSS (card payments).|$|E
25|$|An AME who {{attempts}} the <b>regulatory</b> <b>requirements</b> examination {{as required}} by subsection 566.05(1) and fails will not be entitled to renewal until the examination has been successfully completed.|$|E
5000|$|Eurocontrol Safety <b>Regulatory</b> <b>Requirement</b> (ESARRs) - basis {{requirements}} for certification and designation according to EC regulation 2096/2005.|$|R
5000|$|The first <b>regulatory</b> <b>requirement</b> is {{that rates}} must be adequate; meaning the rates the {{insurers}} charge {{should be able}} to cover expenses.|$|R
5000|$|The European <b>regulatory</b> <b>requirement</b> CTR 21 {{has been}} officially withdrawn. Some {{manufacturers}} prefer to continue meeting CTR 21, {{but there is}} little reason to do so.|$|R
25|$|The 10th {{anniversary of}} SOX {{coincided with the}} passing of the Jumpstart Our Business Startups (JOBS) Act, {{designed}} to give emerging companies an economic boost, and cutting back on a number of <b>regulatory</b> <b>requirements.</b>|$|E
25|$|Remedial {{action is}} {{generally}} subject to {{an array of}} <b>regulatory</b> <b>requirements,</b> and also can be based on assessments of human health and ecological risks where no legislated standards exist or where standards are advisory.|$|E
25|$|Doing Business {{does not}} cover all the {{regulation}}, or all the <b>regulatory</b> <b>requirements.</b> Other types of regulation such as financial market, environment, or intellectual property regulations that are relevant {{for the private sector}} are not considered.|$|E
50|$|All three {{stations}} {{satisfy a}} <b>regulatory</b> <b>requirement</b> of having stations (including ghost ones, capable of serving as emergency exits or fire shelters) no farther than 2000 m (1¼ mi) apart.|$|R
5000|$|Capital Adequacy Ratio (CRAR) under Basel III {{stood at}} 11.79% as on March 31, 2017 against the minimum <b>regulatory</b> <b>requirement</b> of 9.00%. Common equity tier 1 ratio stood at 7.71%.|$|R
5000|$|The second <b>regulatory</b> <b>requirement</b> is {{that rates}} {{must not be}} excessive; meaning rates should not be so high that policyholders are paying more than the actual value of their protection.|$|R
25|$|Approval of genetically-modified foods {{differs from}} country to country {{regarding}} both use and labeling. For this reason, PepsiCo adheres to all relevant <b>regulatory</b> <b>requirements</b> regarding the use of genetically-modified food crops and food ingredients within the countries it operates.|$|E
25|$|In the United Kingdom, purchasers of new-construction ICE {{motorized}} bicycles {{must meet}} {{a host of}} <b>regulatory</b> <b>requirements</b> and pass inspections from the DVLA and MSVA in order to register such machines for operation on public roadways. Owners must obtain an EC-type Motorcycle Single Vehicle Type Approval Certification (MSVA), {{and in order to}} obtain a DVLA-required insurance certificate, must provide proof from the original seller of the bicycle and engine that both the bicycle and the engine are new and unused. ICE motorized bicycles that are amateur-built and meet MSVA safety and regulatory standards, and which meet the definition of low powered mopeds (engines of proven output of less than 1kW (1.34hp) and capable of 25km/h (16mph) or less) face considerably fewer <b>regulatory</b> <b>requirements.</b>|$|E
25|$|At {{the local}} {{government}} level, regional water resource management strategies supported by regional and/or local catchment-scale integrated water cycle management plans and/or stormwater management plans provide the strategic context for WSUD. Local government environment plans may place <b>regulatory</b> <b>requirements</b> on developments to implement WSUD.|$|E
5000|$|Bruitparif is a {{non-profit}} organisation accredited by the région Île-de-France, and the Ministry of Environment {{to monitor the}} environmental noise in Île-de-France. Its missions meet a <b>regulatory</b> <b>requirement</b> and come in three functions: ...|$|R
40|$|Using {{data for}} the period 1995 - 96 to 1999 - 2000, this paper seeks to {{identify}} the factors influencing spreads of Scheduled Commercial Banks in India. Among the explanatory variables, we incorporate, {{in addition to the}} standard set of variables, <b>regulatory</b> <b>requirement</b> variables. Our analysis reveals that (i) size does not necessarily correlate with higher spread, and (ii) higher fee income enables banks to tolerate lower spreads. With regard to <b>regulatory</b> <b>requirement</b> variables, it is found that (i) capital {{plays an important role in}} affecting spreads of public sector banks, and (ii) non-performing assets is uniformly important across all bank groups in influencing spreads. ...|$|R
5000|$|According to the 30 December 1996 law on Air, AIRPARIF is a {{non-profit}} organisation accredited by the Ministry of Environment {{to monitor the}} air quality in Île-de-France. Its missions meet a <b>regulatory</b> <b>requirement</b> and come in four functions: ...|$|R
25|$|Another {{pharmaceutical}} company, Pfizer, terminated the Phase III {{development program}} for its obesity compound otenabant (CP-945,598), a selective antagonist of the CB1 receptor. According to Pfizer their decision {{was based on}} changing regulatory perspectives on the risk/benefit profile of the CB1 class and likely new <b>regulatory</b> <b>requirements</b> for approval.|$|E
25|$|Some {{factors that}} {{influence}} which classification information should be assigned include how much value that information has to the organization, how old the information is {{and whether or not}} the information has become obsolete. Laws and other <b>regulatory</b> <b>requirements</b> are also important considerations when classifying information.|$|E
25|$|The {{estimates}} {{assume that}} a business knows what is required and does not waste time. Satisfying <b>regulatory</b> <b>requirements</b> will obviously take longer if the business lacks information or is unable to follow up promptly. A related {{point here is that}} DB may not understand “work-arounds”, “facilitating fees”, and “learning time” that speed or delay approvals and causes variation costs.|$|E
25|$|Canadian {{financial}} institutions have not adopted IBAN and use bank transit numbers {{issued by the}} Canadian Payments Association for domestic transfers, and SWIFT for international transfers. There is no formal governmental or private sector <b>regulatory</b> <b>requirement</b> in Canada for the major banks to use IBAN.|$|R
2500|$|Some {{portable}} stations append a /P to end {{of their}} call sign (pronounced as [...] "slash portable") to indicate their status as a portable operation. In some countries, this is a <b>regulatory</b> <b>requirement,</b> whereas in others it is done {{at the option of}} the operator.|$|R
50|$|Canadian {{financial}} institutions have not adopted IBAN and use bank transit numbers {{issued by the}} Canadian Payments Association for domestic transfers, and SWIFT for international transfers. There is no formal governmental or private sector <b>regulatory</b> <b>requirement</b> in Canada for the major banks to use IBAN.|$|R
25|$|The federal Schedule 1 drug {{classification}} blocks broad {{scientific research}} on cannabis. However, in late 2015, the United States Drug Enforcement Administration (DEA) eased some <b>regulatory</b> <b>requirements</b> {{imposed by the}} Controlled Substances Act (CSA) {{for those who are}} conducting FDA-approved clinical trials on cannabidiol (CBD). These modifications will streamline the research process regarding CBD’s possible medicinal value and help foster ongoing scientific studies.|$|E
25|$|The first {{successful}} {{solvent extraction process}} for the recovery of pure uranium and plutonium was developed at ORNL in 1949. The PUREX process is the current method of extraction. Separation plants were also constructed at Savannah River Site and a smaller plant at West Valley Reprocessing Plant which closed by 1972 because of its inability to meet new <b>regulatory</b> <b>requirements.</b>|$|E
25|$|By {{avoiding}} an exchange, {{users of}} OTC options can narrowly tailor {{the terms of}} the option contract to suit individual business requirements. In addition, OTC option transactions generally {{do not need to be}} advertised to the market and face little or no <b>regulatory</b> <b>requirements.</b> However, OTC counterparties must establish credit lines with each other, and conform to each other's clearing and settlement procedures.|$|E
5000|$|Some {{portable}} stations append a /P to end {{of their}} call sign (pronounced as [...] "slash portable") to indicate their status as a portable operation. In some countries, this is a <b>regulatory</b> <b>requirement,</b> whereas in others it is done {{at the option of}} the operator.|$|R
5000|$|Provided {{that the}} members of the SSAS pension scheme are also trustees, there is a lesser <b>regulatory</b> <b>requirement</b> than if all members were not trustees. This is because the members of the SSAS pension scheme are deemed to be {{investing}} the funds for themselves.|$|R
50|$|A Protocol {{assessment}} {{does not}} replace an environmental and social impact assessment (ESIA), which takes place over a much {{longer period of time}} as a mandatory <b>regulatory</b> <b>requirement.</b> A Protocol assessment will, amongst other things, check the scope and quality of the ESIA which has been done.|$|R
25|$|As {{with other}} kinds of drugs, the FDA regulates the quality and safety of gene therapy {{products}} and supervises how these products are used clinically. Therapeutic alteration {{of the human genome}} falls under the same <b>regulatory</b> <b>requirements</b> as any other medical treatment. Research involving human subjects, such as clinical trials, must be reviewed and approved by the FDA and an Institutional Review Board.|$|E
25|$|The HACCP {{regulation}} {{requires that}} all plants maintain certain documents, including its hazard analysis and written HACCP plan, and records documenting the monitoring of critical control points, critical limits, verification activities, and {{the handling of}} processing deviations. Implementation involves monitoring, verifying, and validating of the daily work that is compliant with <b>regulatory</b> <b>requirements</b> in all stages all the time. The differences among those three types of work are given by Saskatchewan Agriculture and Food.|$|E
25|$|Two versions, the {{standard}} Model 300 with increased MTOW of 14,000 lb (6,300 kg) and the Model 300LW with MTOW limited to 12,500 lb (5,700 kg) {{to meet the}} aviation <b>regulatory</b> <b>requirements</b> of various countries; 247 built including 35 Model 300LW and including two Model 300s modified and another 17 built specifically for the FAA for use in navaid calibration. The 300LW had a lower certified Take-Off Gross Weight of 12,500 for the European market related to tax.|$|E
40|$|Drug {{dissolution}} {{testing is}} an integral part of drugproduct development and quality assessment. Oftendrug dissolution testing is a <b>regulatory</b> <b>requirement</b> to establish the quality of a drug product [1 - 3]. In reality,drug dissolution testing is a solubility determi-nation technique. It utilizes specialized equipment for tha...|$|R
40|$|Abstract: “Open access ” is a <b>regulatory</b> <b>requirement</b> in many {{countries}} mandating that the residential access network infrastructure be competitively available to service providers. We propose dual Service-Level Agreements (SLAs) to enforce fairness in open access EPON. © 2005 Optical Society of America OCIS codes: (060. 4250) Network...|$|R
50|$|Certified Engineering Technologist is a Canadian {{professional}} title awarded {{on the basis}} of academic qualification and work experience. Abbreviated as C.E.T., most Canadian provincial engineering and applied science technology associations offer this certification. Certification is voluntary and does not represent a provincial <b>regulatory</b> <b>requirement</b> or a statutory required license.|$|R
